Long-term survival of low- and intermediate risk TAVI-patients: a real world, single center comparison of 684 patients treated with the sapien 3 or the sapien XT device.
26 August 2017 (11:00 - 16:00)
Organised by:
Abstract
About the speaker
Amsterdam University Medical Centre (AUMC), Amsterdam (Netherlands (The))
10 More presentations in this session
Access the full session
The Event
ESC Congress 2017
26 August 2017
11:00 CET
